Stifel raised the firm’s price target on Colgate-Palmolive (CL) to $105 from $95 and keeps a Buy rating on the shares. The modest premium the firm applies compared to Procter & Gamble (PG) shares reflects expectations for superior organic sales and volume growth and gross margin expansion over the next 2-3 quarters and reflects accelerating volume trends and solid contribution from pricing, particularly high inflation markets, like Argentina, and in pet nutrition, the analyst tells investors.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CL:
- Colgate-Palmolive price target raised to $91 from $85 at Barclays
- Colgate-Palmolive price target raised to $106 from $100 at Evercore ISI
- Colgate-Palmolive price target raised to $104 from $98 at Deutsche Bank
- Colgate-Palmolive price target raised to $110 from $100 at BofA
- Colgate-Palmolive price target raised to $112 from $103 at Citi